Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Non-Current Assets (2023 - 2025)

Bioadaptives' Other Non-Current Assets history spans 3 years, with the latest figure at $2500.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $2500.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $2500.0 (changed 0.0% YoY), and the annual figure for FY2025 was $2500.0, changed 0.0%.
  • Other Non-Current Assets for Q4 2025 was $2500.0 at Bioadaptives, roughly flat from $2500.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2500.0 in Q4 2023 to a low of $2500.0 in Q4 2023.
  • The 3-year median for Other Non-Current Assets is $2500.0 (2023), against an average of $2500.0.
  • Peak annual rise in Other Non-Current Assets hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Other Non-Current Assets stood at $2500.0 in 2023, then changed by 0.0% to $2500.0 in 2024, then changed by 0.0% to $2500.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $2500.0, $2500.0, and $2500.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.